371 related articles for article (PubMed ID: 30447136)
1. Monocyte-Derived Interleukin-1β As the Driver of S100A12-Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease.
Armaroli G; Verweyen E; Pretzer C; Kessel K; Hirono K; Ichida F; Okabe M; Cabral DA; Foell D; Brown KL; Kessel C
Arthritis Rheumatol; 2019 May; 71(5):792-804. PubMed ID: 30447136
[TBL] [Abstract][Full Text] [Related]
2. Functional benefits of corticosteroid and IVIG combination therapy in a coronary artery endothelial cell model of Kawasaki disease.
Inoue T; Murakami S; Matsumoto K; Matsuda A
Pediatr Rheumatol Online J; 2020 Oct; 18(1):76. PubMed ID: 33023630
[TBL] [Abstract][Full Text] [Related]
3. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12.
Wittkowski H; Hirono K; Ichida F; Vogl T; Ye F; Yanlin X; Saito K; Uese K; Miyawaki T; Viemann D; Roth J; Foell D
Arthritis Rheum; 2007 Dec; 56(12):4174-81. PubMed ID: 18050248
[TBL] [Abstract][Full Text] [Related]
4. An Immunological Axis Involving Interleukin 1β and Leucine-Rich-α2-Glycoprotein Reflects Therapeutic Response of Children with Kawasaki Disease: Implications from the KAWAKINRA Trial.
Kessel C; Koné-Paut I; Tellier S; Belot A; Masjosthusmann K; Wittkowski H; Fuehner S; Rossi-Semerano L; Dusser P; Marie I; Boukhedouni N; Agostini H; Piedvache C; Foell D
J Clin Immunol; 2022 Aug; 42(6):1330-1341. PubMed ID: 35699824
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effect of resveratrol in human coronary arterial endothelial cells via induction of autophagy: implication for the treatment of Kawasaki disease.
Huang FC; Kuo HC; Huang YH; Yu HR; Li SC; Kuo HC
BMC Pharmacol Toxicol; 2017 Jan; 18(1):3. PubMed ID: 28069066
[TBL] [Abstract][Full Text] [Related]
6. Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease.
Qi Y; Gong F; Zhang Q; Xie C; Wang W; Fu S
Arthritis Res Ther; 2012 Nov; 14(6):R251. PubMed ID: 23171632
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
Wu Y; Liu FF; Xu Y; Wang JJ; Samadli S; Wu YF; Liu HH; Chen WX; Luo HH; Zhang DD; Wei W; Hu P
Clin Exp Med; 2019 May; 19(2):173-181. PubMed ID: 30617865
[TBL] [Abstract][Full Text] [Related]
8. Resistin Enhances Inflammatory Cytokine Production in Coronary Artery Tissues by Activating the NF-
Gao F; Si F; Feng S; Yi Q; Liu R
Biomed Res Int; 2016; 2016():3296437. PubMed ID: 27800490
[No Abstract] [Full Text] [Related]
9. Neutrophil-Derived Semaphorin 4D Induces Inflammatory Cytokine Production of Endothelial Cells via Different Plexin Receptors in Kawasaki Disease.
Huang J; Wu S; Cao S; Zhu X; Zhang S
Biomed Res Int; 2020; 2020():6663291. PubMed ID: 33381571
[TBL] [Abstract][Full Text] [Related]
10. Semaphorin 7A promotes endothelial permeability and inflammation via plexin C1 and integrin β1 in Kawasaki disease.
Huang J; Zhao C; Zhang S
BMC Pediatr; 2024 Apr; 24(1):285. PubMed ID: 38678170
[TBL] [Abstract][Full Text] [Related]
11. Clinical indicators combined with S100A12/TLR2 signaling molecules to establish a new scoring model for coronary artery lesions in Kawasaki disease.
Wu Y; Wang S; Zhou Y; Yang Y; Li S; Yin W; Ding Y
PLoS One; 2023; 18(10):e0292653. PubMed ID: 37824465
[TBL] [Abstract][Full Text] [Related]
12. Expression of FcRs on monocytes among Kawasaki disease patients with coronary artery lesions.
Xia Y; Tian X; Li Q; Wang G; Li C; Yang J
Int Immunopharmacol; 2017 Apr; 45():1-5. PubMed ID: 28147297
[TBL] [Abstract][Full Text] [Related]
13. [Changes and significance for regulatory factors for signal pathways of Toll-like receptors in immunological pathogenesis of Kawasaki disease].
Wang GB; Li CR; Zu Y; Yang WG
Zhonghua Er Ke Za Zhi; 2008 Jan; 46(1):49-54. PubMed ID: 18353240
[TBL] [Abstract][Full Text] [Related]
14. Combination of S100A12/TLR2 signaling molecules and clinical indicators in a new predictive model for IVIG-resistant Kawasaki disease.
Wu Y; Liu P; Zhou Y; Yang Y; Li S; Yin W; Liu F; Ding Y
Sci Rep; 2024 Mar; 14(1):7261. PubMed ID: 38538656
[TBL] [Abstract][Full Text] [Related]
15. Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial).
Tremoulet AH; Jain S; Kim S; Newburger J; Arditi M; Franco A; Best B; Burns JC
Contemp Clin Trials; 2016 May; 48():70-5. PubMed ID: 27080929
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory parameters and soluble cell adhesion molecules in Swedish children with Kawasaki disease: relationship to cardiac lesions and intravenous immunoglobulin treatment.
Schiller B; Elinder G
Acta Paediatr; 1999 Aug; 88(8):844-8. PubMed ID: 10503683
[TBL] [Abstract][Full Text] [Related]
17. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
Ge X; Li CR; Yang J; Wang GB
Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
[TBL] [Abstract][Full Text] [Related]
18. Cell adhesion molecule expression in coronary artery aneurysms in acute Kawasaki disease.
Miura M; Garcia FL; Crawford SE; Rowley AH
Pediatr Infect Dis J; 2004 Oct; 23(10):931-6. PubMed ID: 15602193
[TBL] [Abstract][Full Text] [Related]
19. Prednisolone Suppresses the Extracellular Release of HMGB-1 and Associated Inflammatory Pathways in Kawasaki Disease.
Ueno K; Nomura Y; Morita Y; Kawano Y
Front Immunol; 2021; 12():640315. PubMed ID: 34079539
[TBL] [Abstract][Full Text] [Related]
20. [The role of activation of toll-like receptors in immunological pathogenesis of Kawasaki disease].
Wang GB; Li CR; Zu Y; Yuan XW
Zhonghua Er Ke Za Zhi; 2006 May; 44(5):333-6. PubMed ID: 16780707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
